DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Allegra-D 24 Hour (Fexofenadine Hydrochloride / Pseudoephedrine Hydrochloride) - Summary



ALLEGRA-D 24 HOUR (fexofenadine hydrochloride and pseudoephedrine hydrochloride) Extended-Release Tablets for oral administration contain 180 mg fexofenadine hydrochloride for immediate release and 240 mg pseudoephedrine hydrochloride for extended release.

ALLEGRA-D 24 HOUR Extended-Release Tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. Symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion.

ALLEGRA-D 24 HOUR should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see CLINICAL PHARMACOLOGY).

See all Allegra-D 24 Hour indications & dosage >>


Media Articles Related to Allegra-D 24 Hour (Fexofenadine / Pseudoephedrine)

ICD-10 Follies: Allergic Rhinitis Due to Pollen
Source: MedPage Today Allergy & Immunology [2014.03.22]
(MedPage Today) -- Yes, there's a code for that. To mark the forthcoming move to the ICD-10 coding system, MedPage Today is spotlighting some of those thousands of new codes that might just be getting a bit too granular.

FDA OKs Sublingual Grastek for Timothy Grass Pollen Allergy
Source: Medscape Allergy & Clinical Immunology Headlines [2014.04.14]
The FDA approved a grass pollen allergen extract for the treatment of Timothy grass pollen-induced allergic rhinitis, with or without conjunctivitis, in individuals aged 5 to 65 years.
FDA Approvals

FDA approves first sublingual allergen extract for the treatment of certain grass pollen allergies
Source: Allergy News From Medical News Today [2014.04.04]
The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in...

more news >>

Clinical Trials Related to Allegra-D 24 Hour (Fexofenadine / Pseudoephedrine)

A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge [Recruiting]
An H3 receptor antagonist should reduce the congestion associated with allergic rhinitis. A nasal allergen challenge will be given to patients to induce rhinitis symptoms and acoustic rhinometry will be used to measure the congestion.

more trials >>

Page last updated: 2014-04-14

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012